Immediate Impact

1 from Science/Nature 61 standout
Sub-graph 1 of 23

Citing Papers

Illusory generalizability of clinical prediction models
2024 StandoutScience
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
2 intermediate papers

Works of C.G.G. Link being referenced

A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, ‘Seroquel’) and haloperidol in schizophrenia
2000
A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia
1997

Author Peers

Author Last Decade Papers Cites
C.G.G. Link 488 137 50 76 14 570
A. Torbeyns 527 86 44 79 14 649
S. Heylen 444 92 16 94 10 551
Shubhra Mace 273 123 14 54 14 459
A Breier 464 92 40 139 8 539
W. Chrzanowski 398 117 20 108 11 481
B.I. Diamond 280 94 57 60 23 601
Cedric O’Gorman 433 77 41 75 30 586
Richard M. Steinbook 330 72 18 83 21 500
Ataru Inagaki 379 73 16 42 23 620
H. De Cuyper 325 272 14 66 14 593

All Works

Loading papers...

Rankless by CCL
2026